Xingchen Liu
- Biotechnology top 10%
-
- Electrospun Nanofibers in Biomedical Applications 3
-
- Protein Degradation and Inhibitors 5
- Machine Learning in Bioinformatics 3
- Epigenetics and DNA Methylation 3
-
- CAR-T cell therapy research 6
- PARP inhibition in cancer therapy 3
-
- Tissue Engineering and Regenerative Medicine 4
-
- Tracheal and airway disorders 3
- Journals
- European Journal of Medicinal Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xingchen Liu
55 papers receiving 827 citations
Peers
Comparison fields: 5 of 113
- Biotechnology 64
- Biochemistry 34
- Biomaterials 74
- Cancer Research 83
- Molecular Biology 342
Countries citing papers authored by Xingchen Liu
This map shows the geographic impact of Xingchen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingchen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingchen Liu more than expected).
Fields of papers citing papers by Xingchen Liu
This network shows the impact of papers produced by Xingchen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingchen Liu. The network helps show where Xingchen Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xingchen Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 33 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 21 | |
| 14 | 2022 | 38 | |
| 15 | 2018 | 0 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 14 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 57 | |
| 20 | Application of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as the First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer | 2010 | 3 |
About Xingchen Liu
Xingchen Liu is a scholar working on Oncology, Urology and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 838 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Protein Degradation and Inhibitors (5 papers), Tissue Engineering and Regenerative Medicine (4 papers), Machine Learning in Bioinformatics (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Tracheal and airway disorders (3 papers), PARP inhibition in cancer therapy (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Biotechnology (64 citations), Biochemistry (34 citations) and Biomaterials (74 citations). Xingchen Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaobing Wang, Fucheng Yin, Lingyi Kong, Shang Li, Dehua Lu, Lailiang Qu, Heng Luo, Xiaojun Liao, Zhijian Sun and Yan Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Frontiers in Immunology, Bioorganic Chemistry and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.